Recruiting Brain Cancer Studies in Montvale
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC....
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given together in people with a glioma that either...
About Brain Cancer Clinical Trials in Montvale
Brain cancer includes tumors that originate in the brain (primary) or spread from other areas (metastatic). Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Treatment typically combines surgery, radiation, and chemotherapy, with immunotherapy trials underway.
There are currently 2 brain cancer clinical trials recruiting participants in Montvale, NEW%20JERSEY. These studies are seeking a combined 119 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Brain Cancer Clinical Trials in Montvale — FAQ
Are there brain cancer clinical trials in Montvale?
Yes, there are 2 brain cancer clinical trials currently recruiting in Montvale, NEW%20JERSEY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Montvale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Montvale research site will contact you about next steps.
Are clinical trials in Montvale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Montvale studies also compensate for your time and travel.
What brain cancer treatments are being tested?
The 2 active trials in Montvale are testing new therapies including novel drugs, biologics, and treatment approaches for brain cancer.
Data updated March 2, 2026 from ClinicalTrials.gov